Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
influenza virus vaccine quadrivalent
- Development stage
- Phase 3
- Lead developer
- Il-Yang Pharmaceutical
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
IL-YANG Quadrivalent Influenza Vaccine is an inactivated, split-virion seasonal influenza vaccine developed by the South Korean company Il-Yang Pharmaceutical. The vaccine is designed to provide protection against four distinct strains of the influenza virus, typically including two influenza A subtypes (H1N1 and H3N2) and two influenza B lineages (Victoria and Yamagata). It has been evaluated in Phase III clinical trials in South Korea for safety and immunogenicity in both healthy adults and pediatric populations (children and adolescents). The vaccine is administered via intramuscular injection and aims to elicit a robust immune response against circulating seasonal flu strains.
- Brand names
- IL-YANG Quadrivalent Influenza Vaccine Inj.Il-Yang Quadrivalent Seasonal Influenza Vaccine
- Other names
- quadrivalent influenza vaccine, split virion, inactivated
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on influenza virus vaccine quadrivalent.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on influenza virus vaccine quadrivalent.